Table 3 |
|||||
|
Functional comparison of SMAD responsive (from gene expression) and SMAD-target (from ChIP-chip) gene sets obtained using Ingenuity Core analyses |
|||||
|
IPA Signaling Pathway |
Affymetrix (1095 genes) |
SMAD predicted (150 targets) |
|||
|
|
|||||
|
IPA ratio |
IPA p-value |
No. molecules |
IPA ratio |
IPA molecules |
|
|
|
|||||
|
TGF-beta signaling |
0.169 |
3.68E-06 |
14 |
0.012 |
SMAD3 |
|
|
|||||
|
RAR activation |
0.08 |
2.50E-03 |
15 |
0.011 |
GTF2H2, SMAD3 |
|
|
|||||
|
IGF-1 signaling |
0.108 |
3.58E-03 |
10 |
n/a |
n/a |
|
|
|||||
|
Wnt/beta-catenin signaling |
0.084 |
4.12E-03 |
14 |
0.018 |
CSNK1A1, DKK1, FRAT1 |
|
|
|||||
|
Cell cycle: G1/S checkpoint regulation |
0.117 |
7.37E-03 |
7 |
0.033 |
HDAC9, SMAD3 |
|
|
|||||
|
BMP signaling |
0.097 |
1.01E-02 |
10 |
n/a |
n/a |
|
|
|||||
|
GM-CSF signaling |
0.113 |
1.34E-02 |
7 |
0.016 |
CAMK2D |
|
|
|||||
|
LPS/IL-1 mediated inhibition of RXR function |
0.065 |
2.68E-02 |
13 |
n/a |
n/a |
|
|
|||||
|
IL-4 signaling |
0.1 |
5.15E-02 |
7 |
0.014 |
NFAT5 |
|
|
|||||
|
Only significant signaling pathways are listed. Ratio shows the relative overlap between number of molecules per pathway within each dataset over the total number of pathway-specific molecules present in Ingenuity Knowledge Base. |
|||||
|
Qin et al. BMC Systems Biology 2009 3:73 doi:10.1186/1752-0509-3-73 |
|||||